These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9725542)

  • 1. Assessment of drug accumulation in the evaluation of pharmacokinetic data.
    Meineke I; Gleiter CH
    J Clin Pharmacol; 1998 Aug; 38(8):680-4. PubMed ID: 9725542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico drug absorption tract: An agent-based biomimetic model for human oral drug absorption.
    Deng J; Jhandey A; Zhu X; Yang Z; Yik KFP; Zuo Z; Lam TN
    PLoS One; 2018; 13(8):e0203361. PubMed ID: 30169515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of pseudo-profiles in organ pharmacokinetics and toxicokinetics.
    Mager H; Göller G
    Stat Med; 1995 May 15-30; 14(9-10):1009-24. PubMed ID: 7569497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Model for Predicting the Interindividual Variability of Drug-Drug Interactions.
    Tod M; Bourguignon L; Bleyzac N; Goutelle S
    AAPS J; 2017 Mar; 19(2):497-509. PubMed ID: 27924615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic evaluation of dose accumulation studies in clinical pharmacokinetics.
    Li L; Li X; Xu L; Sheng Y; Huang J; Zheng Q
    Curr Drug Metab; 2013 Jun; 14(5):605-15. PubMed ID: 23701162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
    Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
    Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic simulation of biowaiver criteria: the effects of gastric emptying, dissolution, absorption and elimination rates.
    Kortejärvi H; Urtti A; Yliperttula M
    Eur J Pharm Sci; 2007 Feb; 30(2):155-66. PubMed ID: 17187967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A point estimator for the time course of drug release.
    Koehne-Voss S; Pigeot I
    Biom J; 2009 Feb; 51(1):146-58. PubMed ID: 19219906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique approach for calculation of absorption rate constant.
    Pidgeon C; Pitlick WH
    Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):467-75. PubMed ID: 928947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Human Pharmacokinetic Prediction of Hepatically Metabolized Drugs With Species-Specific Systemic Clearance.
    Horiuchi K; Ohnishi S; Matsuzaki T; Funaki S; Watanabe A; Mizutare T; Matsumoto S; Nezasa KI; Hasegawa H
    J Pharm Sci; 2018 May; 107(5):1443-1453. PubMed ID: 29331382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The application of sample pooling methods for determining AUC, AUMC and mean residence times in pharmacokinetic studies.
    Cheung BW; Cartier LL; Russlie HQ; Sawchuk RJ
    Fundam Clin Pharmacol; 2005 Jun; 19(3):347-54. PubMed ID: 15910659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective Predictions of Human Pharmacokinetics for Eighteen Compounds.
    Zhang T; Heimbach T; Lin W; Zhang J; He H
    J Pharm Sci; 2015 Sep; 104(9):2795-806. PubMed ID: 25690565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
    Tett SE; Saint-Marcoux F; Staatz CE; Brunet M; Vinks AA; Miura M; Marquet P; Kuypers DR; van Gelder T; Cattaneo D
    Transplant Rev (Orlando); 2011 Apr; 25(2):47-57. PubMed ID: 21190834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finding T
    Han YR; Lee PI; Pang KS
    Drug Metab Dispos; 2018 Nov; 46(11):1796-1804. PubMed ID: 30135243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A two-dimensional mathematical model of non-linear dual-sorption of percutaneous drug absorption.
    George K
    Biomed Eng Online; 2005 Jul; 4():40. PubMed ID: 15992411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simulation for clinical repeated-dose pharmacokinetic trials applying a peak-and-trough sampling design to estimate oral clearance.
    Ishida K; Kayano Y; Taguchi M; Hashimoto Y
    Biol Pharm Bull; 2007 Nov; 30(11):2159-62. PubMed ID: 17978492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simulation studies of errors of parameter estimates in pharmacokinetics.
    Betzien G; Kaufmann B; Schneider B; Ritschel WA
    Arzneimittelforschung; 1985; 35(1):7-14. PubMed ID: 3838673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computer simulations of bioequivalence trials: selection of design and analyte in BCS drugs with first-pass hepatic metabolism: linear kinetics (I).
    Fernández-Teruel C; Nalda Molina R; González-Alvarez I; Navarro-Fontestad C; García-Arieta A; Casabó VG; Bermejo M
    Eur J Pharm Sci; 2009 Jan; 36(1):137-46. PubMed ID: 19028574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.